Ignite Creation Date:
2025-12-25 @ 2:11 AM
Ignite Modification Date:
2026-06-06 @ 6:32 PM
Study NCT ID:
NCT05388760
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-11-05
First Post:
2022-05-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tralokinumab Monotherapy for Children With Moderate-to-severe Atopic Dermatitis - TRAPEDS 1 (TRAlokinumab PEDiatric Trial no. 1)
Sponsor:
LEO Pharma
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Atopic Dermatitis | View |
Keywords: